CHEST EXPANSION DECREASED

This adverse event was reported 64 times

These drugs are most commonly taken by patients reporting CHEST EXPANSION DECREASED:

# Drug Count
0 CELECOXIB 15
1 ADALIMUMAB 14
2 METHOTREXATE 12
3 METHOTREXATE SODIUM 12
4 DIMETHICONE 11
5 ERGOCALCIFEROL 11
6 GLYCERIN 11
7 PIROXICAM 11
8 CALCIUM 9
9 INFLIXIMAB 9
See all common drugs associated with CHEST EXPANSION DECREASED

CHEST EXPANSION DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GLYBURIDE AND METFORMIN HYDROCHLORIDE 1 0.0045
1 PIROXICAM 11 0.0023
2 CALCIUM GLUCONATE 8 0.0013
3 IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE 1 0.0011
4 INFLIXIMAB-DYYB 5 0.0010
5 NITRIC OXIDE 1 0.0010
6 BUTALBITAL, ASPIRIN, AND CAFFEINE 1 0.0008
7 VECURONIUM BROMIDE 1 0.0007
8 OXAPROZIN 1 0.0006
9 DESVENLAFAXINE SUCCINATE 1 0.0005
See all drugs enriched for association with CHEST EXPANSION DECREASED

CHEST EXPANSION DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0001
1 Tetracycline-class Drug [EPC] 1 0.0000
2 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
3 Insulin Analog [EPC] 1 0.0000
See all drug classes enriched for association with CHEST EXPANSION DECREASED